Ikena Oncology Inc. (IKNA) NASDAQ
$1.43 0.03 (2.14%)
Market Cap: $69.01M
As of 05/17/24 04:00 PM EDT. Market closed.
Ikena Oncology Inc. (IKNA)
NASDAQ
$1.43
0.03 (2.14%)
Market Cap: $69.01M
As of 05/17/24 04:00 PM EDT. Market closed.
ikena oncology (formerly kyn therapeutics) is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients, by understanding what drives their disease. we are advancing multiple development and discovery programs: an ep4 receptor antagonist; an ahr antagonist; a kynurenine-degrading enzyme; a discovery-stage program targeting ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
ORBIMED ADVISORS LLC | Director | Jun 24, 2022 | Buy | $4.96 | 162,000 | 803,975 | 2,098,097 | Jun 24, 2022, 05:39 PM |
ORBIMED ADVISORS LLC | Director | Jun 23, 2022 | Buy | $3.71 | 23,419 | 86,884 | 1,936,097 | Jun 24, 2022, 05:39 PM |
ORBIMED ADVISORS LLC | Director | Jun 22, 2022 | Buy | $3.55 | 66,806 | 237,161 | 1,912,678 | Jun 24, 2022, 05:39 PM |
Bonita David P | Director | Jun 23, 2022 | Buy | $3.71 | 23,419 | 86,884 | 1,936,097 | Jun 24, 2022, 05:32 PM |
Bonita David P | Director | Jun 22, 2022 | Buy | $3.55 | 66,806 | 237,161 | 1,912,678 | Jun 24, 2022, 05:32 PM |
Bonita David P | Director | Jun 24, 2022 | Buy | $4.96 | 162,000 | 803,975 | 2,098,097 | Jun 24, 2022, 05:32 PM |
Tessier Maude | Chief Business Officer | Jan 18, 2022 | Option Exercise | $3.54 | 71,786 | 253,800 | 100,578 | Jan 20, 2022, 04:30 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Jan 11, 2022 | Option Exercise | $2.15 | 964 | 2,069 | 45,439 | Jan 12, 2022, 07:25 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Jan 10, 2022 | Option Exercise | $2.15 | 36 | 77 | 44,511 | Jan 12, 2022, 07:25 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Jan 10, 2022 | Sale | $12.00 | 36 | 432 | 44,475 | Jan 12, 2022, 07:25 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Jan 11, 2022 | Sale | $12.00 | 964 | 11,568 | 44,475 | Jan 12, 2022, 07:25 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Dec 10, 2021 | Option Exercise | $2.15 | 1,000 | 2,146 | 45,475 | Dec 14, 2021, 08:48 PM |
Zhang Xiaoyan Michelle | Chief Scientific Officer | Dec 10, 2021 | Sale | $14.76 | 1,000 | 14,760 | 44,475 | Dec 14, 2021, 08:48 PM |
FORMELA JEAN FRANCOIS | Director | Mar 30, 2021 | Buy | $16.00 | 125,000 | 2,000,000 | 874,634 | Dec 14, 2021, 08:29 PM |
FORMELA JEAN FRANCOIS | Director | Dec 13, 2021 | Sale | $14.64 | 8,330 | 121,951 | 1,247,894 | Dec 14, 2021, 08:29 PM |
FORMELA JEAN FRANCOIS | Director | Dec 10, 2021 | Sale | $15.03 | 11,989 | 180,195 | 1,256,224 | Dec 14, 2021, 08:29 PM |
FORMELA JEAN FRANCOIS | Director | Dec 14, 2021 | Sale | $14.00 | 5,959 | 83,426 | 1,241,935 | Dec 14, 2021, 08:29 PM |
Atlas Venture Fund XI, L.P. | 10% Owner | Mar 30, 2021 | Buy | $16.00 | 125,000 | 2,000,000 | 874,634 | Dec 14, 2021, 08:27 PM |
Atlas Venture Fund XI, L.P. | 10% Owner | Dec 14, 2021 | Sale | $14.00 | 5,959 | 83,426 | 1,241,935 | Dec 14, 2021, 08:27 PM |
Atlas Venture Fund XI, L.P. | 10% Owner | Dec 13, 2021 | Sale | $14.64 | 8,330 | 121,951 | 1,247,894 | Dec 14, 2021, 08:27 PM |
Atlas Venture Fund XI, L.P. | 10% Owner | Dec 10, 2021 | Sale | $15.03 | 11,989 | 180,195 | 1,256,224 | Dec 14, 2021, 08:27 PM |
Bonita David P | Director | Mar 30, 2021 | Buy | $16.00 | 423,400 | 6,774,400 | 1,845,872 | Apr 14, 2021, 06:29 PM |
ORBIMED ADVISORS LLC | Director | Mar 30, 2021 | Buy | $16.00 | 423,400 | 6,774,400 | 1,845,872 | Apr 13, 2021, 06:36 PM |
Stampacchia Otello | Director | Mar 30, 2021 | Option Exercise | $16.00 | 450,000 | 7,200,000 | 2,249,123 | Apr 01, 2021, 06:16 PM |
Bonita David P | Director | Mar 30, 2021 | Buy | $16.00 | 423,400 | 6,774,400 | 2,191,425 | Apr 01, 2021, 06:14 PM |
ORBIMED ADVISORS LLC | Director | Mar 30, 2021 | Buy | $16.00 | 423,400 | 6,774,400 | 2,191,425 | Apr 01, 2021, 06:13 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 12,048,773 | 0.66% | No change | Other |
ORBIMED ADVISORS LLC | 3,539,358 | 0.09% | No change | Other |
BLACKROCK INC. | 1,828,752 | 0.00006% | -1.58% | Other |
RENAISSANCE TECHNOLOGIES LLC | 776,600 | 0.00173% | New | Other |
GEODE CAPITAL MANAGEMENT, LLC | 597,277 | 0.00008% | 12.83% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 287,900 | 0.00077% | No change | Other |
JET CAPITAL INVESTORS L P | 0 | 0% | New | Event Driven |
Period of Report: 03/31/2024
10-K/10-Q Filings: View